Sarepta Therapeutics Inc (SRPT) stock soared on Thursday as the biotech announced positive study results from human tests for its anti-Ebola drug candidate.
Sarepta's Anti-Ebola Drug Shows No Side Effects; Stock Soars 10% In After-Hours
Bidness etc. - 17 Oct 2014 13:09
Sarepta Therapeutics Inc (SRPT) stock soared on Thursday as the biotech announced positive study results from human tests for its anti-Ebola drug candidate.
Share this Article
Comment on this Article
Recommended
Please to comment